文献速递鼻科头颈外科

鼻窦癌中微小RNA失调及miR-21作为鼻窦鳞癌预后标志物的价值

Deregulation of selected microRNAs in sinonasal carcinoma: Value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma.
PubMed 文献 · Head Neck · 2017-09-28

该研究采用实时定量PCR比较70例鼻窦癌组织与17例对照组织中miR-21、miR-141和miR-200c的表达。结果显示miR-21在鼻窦癌中显著上调,而miR-141和miR-200c均低于可检测水平。

要点

  • miR-21在鼻窦癌组织中表达显著上调。
  • miR-141与miR-200c在癌与正常组织中均低于可检测水平。

核心结论

  • miR-21上调可能参与鼻窦癌的肿瘤发生,并与不良预后相关。
  • miR-21或可作为有价值的预后生物标志物。

研究设计与样本

  • 研究采用实时定量PCR比较70例鼻窦癌组织(多数为鳞状细胞癌)与17例对照鼻窦组织的相对表达。

主要发现

  • miR-21在鼻窦癌组织中显著上调。
  • miR-141和miR-200c在鼻窦癌样本和健康组织中均低于可检测水平。

关键数值与推荐

  • miR-21高表达定义为最高四分位。

临床怎么用

  • miR-21可能作为鼻窦鳞癌的预后生物标志物,用于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumors occurring in the sinonasal area are characterized by unfavorable outcome due to difficult diagnosis, treatment, and prognosis of the disease corresponding with the anatomic complexity of the area. METHODS: We used quantitative real-time polymerase chain reaction (PCR) to compare relative expression of miR-21, miR-141, and miR-200c in 70 formalin-fixed, paraffin-embedded samples of sinonasal carcinoma tissue (majority of squamous cell carcinoma [SCC] samples) with 17 control samples of sinonasal tissue. RESULTS: Our data showed significant upregulation of miR-21 in sinonasal cancer tissue. Expression levels of miR-141 and miR-200c were below detectable levels in both sinonasal cancer samples and healthy tissue. Kaplan-Meier analysis with log-rank survival showed that patients with SCC with high expression of miR-21 (highest quartile) had impaired survival close to reaching statistical significance (P = .0630). CONCLUSION: Our results suggest that miR-21 upregulation is involved in tumorigenesis of sinonasal carcinoma and that it is associated with poor prognosis. Thus, miR-21 could be used as a valuable prognostic biomarker.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Kovarikova H, Bubancova I, Laco J, et al. Deregulation of selected microRNAs in sinonasal carcinoma: Value of miR-21 as prognostic biomarker in sinonasal squamous cell carcinoma. Head Neck. 2017. PMID: 28960576. doi:10.1002/hed.24930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。